港股異動 | 中國中冶(1618.HK)AH股均大漲 擬出售應收賬款盤活資產
格隆匯12月18日丨中國中冶(1618.HK)股價低位反彈漲6.06%,報1.4港元,最新總市值290.1億港元;公司A股現報2.84元,漲幅5.97%。公司昨日公告稱,附屬公司上海寶冶與申港證券訂立買賣協議,上海寶冶同意出售而申港證券(代表專項計劃)同意以預計代價不超過人民幣28.73億元收購預計賬面值不超過人民幣30億元的應收賬款。公司認為,董事會認為本次交易將起到盤活資產的效果;控制應收賬款的風險;降低應收賬款金額從而優化集團的資產結構;及增加集團的流動資金、提高資產效率並改善財務狀況,進而優化財務報表。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.